265 related articles for article (PubMed ID: 27239411)
1. Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting.
Penna F; Bonetto A; Aversa Z; Minero VG; Rossi Fanelli F; Costelli P; Muscaritoli M
J Cachexia Sarcopenia Muscle; 2016 Jun; 7(3):345-54. PubMed ID: 27239411
[TBL] [Abstract][Full Text] [Related]
2. Interference with Ca
Pin F; Minero VG; Penna F; Muscaritoli M; De Tullio R; Baccino FM; Costelli P
Front Physiol; 2017; 8():213. PubMed ID: 28469577
[TBL] [Abstract][Full Text] [Related]
3. IGF-1 is downregulated in experimental cancer cachexia.
Costelli P; Muscaritoli M; Bossola M; Penna F; Reffo P; Bonetto A; Busquets S; Bonelli G; Lopez-Soriano FJ; Doglietto GB; Argilés JM; Baccino FM; Rossi Fanelli F
Am J Physiol Regul Integr Comp Physiol; 2006 Sep; 291(3):R674-83. PubMed ID: 16614058
[TBL] [Abstract][Full Text] [Related]
4. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
[TBL] [Abstract][Full Text] [Related]
5. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract][Full Text] [Related]
6. Muscle wasting in diabetic and in tumor-bearing rats: role of oxidative stress.
Mastrocola R; Reffo P; Penna F; Tomasinelli CE; Boccuzzi G; Baccino FM; Aragno M; Costelli P
Free Radic Biol Med; 2008 Feb; 44(4):584-93. PubMed ID: 18053817
[TBL] [Abstract][Full Text] [Related]
7. Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats.
Costelli P; Bossola M; Muscaritoli M; Grieco G; Bonelli G; Bellantone R; Doglietto GB; Baccino FM; Rossi Fanelli F
Cytokine; 2002 Jul; 19(1):1-5. PubMed ID: 12200106
[TBL] [Abstract][Full Text] [Related]
8. The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia.
Moore-Carrasco R; Busquets S; Almendro V; Palanki M; López-Soriano FJ; Argilés JM
Int J Oncol; 2007 May; 30(5):1239-45. PubMed ID: 17390027
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.
Carbó N; López-Soriano J; Costelli P; Busquets S; Alvarez B; Baccino FM; Quinn LS; López-Soriano FJ; Argilés JM
Br J Cancer; 2000 Aug; 83(4):526-31. PubMed ID: 10945502
[TBL] [Abstract][Full Text] [Related]
10. Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation.
Wyke SM; Russell ST; Tisdale MJ
Br J Cancer; 2004 Nov; 91(9):1742-50. PubMed ID: 15477867
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice.
Fermoselle C; García-Arumí E; Puig-Vilanova E; Andreu AL; Urtreger AJ; de Kier Joffé ED; Tejedor A; Puente-Maestu L; Barreiro E
Exp Physiol; 2013 Sep; 98(9):1349-65. PubMed ID: 23625954
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models.
Busquets S; Fuster G; Ametller E; Olivan M; Figueras M; Costelli P; Carbó N; Argilés JM; López-Soriano FJ
Clin Nutr; 2007 Apr; 26(2):239-44. PubMed ID: 17261345
[TBL] [Abstract][Full Text] [Related]
14. L-leucine dietary supplementation modulates muscle protein degradation and increases pro-inflammatory cytokines in tumour-bearing rats.
Cruz B; Oliveira A; Gomes-Marcondes MCC
Cytokine; 2017 Aug; 96():253-260. PubMed ID: 28494385
[TBL] [Abstract][Full Text] [Related]
15. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.
Busquets S; Figueras MT; Fuster G; Almendro V; Moore-Carrasco R; Ametller E; Argilés JM; López-Soriano FJ
Cancer Res; 2004 Sep; 64(18):6725-31. PubMed ID: 15374990
[TBL] [Abstract][Full Text] [Related]
16. Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice.
Brown JL; Lee DE; Rosa-Caldwell ME; Brown LA; Perry RA; Haynie WS; Huseman K; Sataranatarajan K; Van Remmen H; Washington TA; Wiggs MP; Greene NP
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):987-1002. PubMed ID: 30328290
[TBL] [Abstract][Full Text] [Related]
17. Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia.
Costelli P; De Tullio R; Baccino FM; Melloni E
Br J Cancer; 2001 Apr; 84(7):946-50. PubMed ID: 11286475
[TBL] [Abstract][Full Text] [Related]
18. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma.
Baracos VE; DeVivo C; Hoyle DH; Goldberg AL
Am J Physiol; 1995 May; 268(5 Pt 1):E996-1006. PubMed ID: 7539218
[TBL] [Abstract][Full Text] [Related]
19. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis.
Llovera M; Garcia-Martinez C; Agell N; Lopez-Soriano FJ; Argiles JM
Int J Cancer; 1995 Mar; 61(1):138-41. PubMed ID: 7705927
[TBL] [Abstract][Full Text] [Related]
20. Moderate Exercise Improves Experimental Cancer Cachexia by Modulating the Redox Homeostasis.
Ballarò R; Penna F; Pin F; Gómez-Cabrera MC; Viña J; Costelli P
Cancers (Basel); 2019 Feb; 11(3):. PubMed ID: 30823492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
